Page last updated: 2024-11-01

nortriptyline and Ophthalmoplegia, Progressive Supranuclear

nortriptyline has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies

Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamai, S1
Almeida, OP1

Other Studies

1 other study available for nortriptyline and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Nortriptyline for the treatment of depression in progressive supranuclear palsy.
    Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:8

    Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents,

1997